Global Complementary DNA Microarrays (cDNA) 麻豆原创 Research Report 2023

Publication ID:

PB510234184

Publication Date:

October 3, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Semiconductors [2]

Computing & Electronics [3]

Description:

In genetics, complementary DNA (cDNA) is DNA synthesized from a single-stranded RNA (e.g., messenger RNA (mRNA) or microRNA (miRNA)) template in a reaction catalyzed by the enzyme reverse transcriptase. cDNA is often used to clone eukaryotic genes in prokaryotes. When scientists want to express a specific protein in a cell that does not normally express that protein (i.e., heterologous expression), they will transfer the cDNA that codes for the protein to the recipient cell. In molecular biology, cDNA is also generated to analyze transcriptomic profiles in bulk tissue, single cells, or single nuclei in assays such as microarrays and RNA-seq.
The global Complementary DNA Microarrays (cDNA) market is projected to reach US$ 46 million in 2029, increasing from US$ 35 million in 2022, with the CAGR of 4.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Complementary DNA Microarrays (cDNA) market research.
Key companies engaged in the Complementary DNA Microarrays (cDNA) industry include Illumnia, Affymetrix, Agilent, Scienion AG, Applied Microarrays, Arrayit, Sengenics, Biometrix Technology and Savyon Diagnostics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Complementary DNA Microarrays (cDNA) were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Complementary DNA Microarrays (cDNA) market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Complementary DNA Microarrays (cDNA) market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen
Segment by Type
Gene expression
Genotyping
Genome cytogenetics
Segment by Application
Oncology
Non-invasive pregnancy testing(NIPT)
Hypertension
diabetes
Nervous system diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Complementary DNA Microarrays (cDNA) report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Complementary DNA Microarrays (cDNA) 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Gene expression
1.2.3 Genotyping
1.2.4 Genome cytogenetics
1.3 麻豆原创 by Application
1.3.1 Global Complementary DNA Microarrays (cDNA) 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Non-invasive pregnancy testing(NIPT)
1.3.4 Hypertension
1.3.5 diabetes
1.3.6 Nervous system diseases
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Complementary DNA Microarrays (cDNA) 麻豆原创 Perspective (2018-2029)
2.2 Complementary DNA Microarrays (cDNA) Growth Trends by Region
2.2.1 Global Complementary DNA Microarrays (cDNA) 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Complementary DNA Microarrays (cDNA) Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Complementary DNA Microarrays (cDNA) Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Complementary DNA Microarrays (cDNA) 麻豆原创 Dynamics
2.3.1 Complementary DNA Microarrays (cDNA) Industry Trends
2.3.2 Complementary DNA Microarrays (cDNA) 麻豆原创 Drivers
2.3.3 Complementary DNA Microarrays (cDNA) 麻豆原创 Challenges
2.3.4 Complementary DNA Microarrays (cDNA) 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Complementary DNA Microarrays (cDNA) Players by Revenue
3.1.1 Global Top Complementary DNA Microarrays (cDNA) Players by Revenue (2018-2023)
3.1.2 Global Complementary DNA Microarrays (cDNA) Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Complementary DNA Microarrays (cDNA) 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Complementary DNA Microarrays (cDNA) Revenue
3.4 Global Complementary DNA Microarrays (cDNA) 麻豆原创 Concentration Ratio
3.4.1 Global Complementary DNA Microarrays (cDNA) 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Complementary DNA Microarrays (cDNA) Revenue in 2022
3.5 Complementary DNA Microarrays (cDNA) Key Players Head office and Area Served
3.6 Key Players Complementary DNA Microarrays (cDNA) Product Solution and Service
3.7 Date of Enter into Complementary DNA Microarrays (cDNA) 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Complementary DNA Microarrays (cDNA) Breakdown Data by Type
4.1 Global Complementary DNA Microarrays (cDNA) Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Complementary DNA Microarrays (cDNA) Forecasted 麻豆原创 Size by Type (2024-2029)
5 Complementary DNA Microarrays (cDNA) Breakdown Data by Application
5.1 Global Complementary DNA Microarrays (cDNA) Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Complementary DNA Microarrays (cDNA) Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Complementary DNA Microarrays (cDNA) 麻豆原创 Size (2018-2029)
6.2 North America Complementary DNA Microarrays (cDNA) 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Complementary DNA Microarrays (cDNA) 麻豆原创 Size by Country (2018-2023)
6.4 North America Complementary DNA Microarrays (cDNA) 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Complementary DNA Microarrays (cDNA) 麻豆原创 Size (2018-2029)
7.2 Europe Complementary DNA Microarrays (cDNA) 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Complementary DNA Microarrays (cDNA) 麻豆原创 Size by Country (2018-2023)
7.4 Europe Complementary DNA Microarrays (cDNA) 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Complementary DNA Microarrays (cDNA) 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Complementary DNA Microarrays (cDNA) 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Complementary DNA Microarrays (cDNA) 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Complementary DNA Microarrays (cDNA) 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Complementary DNA Microarrays (cDNA) 麻豆原创 Size (2018-2029)
9.2 Latin America Complementary DNA Microarrays (cDNA) 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Complementary DNA Microarrays (cDNA) 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Complementary DNA Microarrays (cDNA) 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Complementary DNA Microarrays (cDNA) 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Complementary DNA Microarrays (cDNA) 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Complementary DNA Microarrays (cDNA) 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Complementary DNA Microarrays (cDNA) 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumnia
11.1.1 Illumnia Company Detail
11.1.2 Illumnia Business Overview
11.1.3 Illumnia Complementary DNA Microarrays (cDNA) Introduction
11.1.4 Illumnia Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.1.5 Illumnia Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Detail
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix Complementary DNA Microarrays (cDNA) Introduction
11.2.4 Affymetrix Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.2.5 Affymetrix Recent Development
11.3 Agilent
11.3.1 Agilent Company Detail
11.3.2 Agilent Business Overview
11.3.3 Agilent Complementary DNA Microarrays (cDNA) Introduction
11.3.4 Agilent Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.3.5 Agilent Recent Development
11.4 Scienion AG
11.4.1 Scienion AG Company Detail
11.4.2 Scienion AG Business Overview
11.4.3 Scienion AG Complementary DNA Microarrays (cDNA) Introduction
11.4.4 Scienion AG Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.4.5 Scienion AG Recent Development
11.5 Applied Microarrays
11.5.1 Applied Microarrays Company Detail
11.5.2 Applied Microarrays Business Overview
11.5.3 Applied Microarrays Complementary DNA Microarrays (cDNA) Introduction
11.5.4 Applied Microarrays Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.5.5 Applied Microarrays Recent Development
11.6 Arrayit
11.6.1 Arrayit Company Detail
11.6.2 Arrayit Business Overview
11.6.3 Arrayit Complementary DNA Microarrays (cDNA) Introduction
11.6.4 Arrayit Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.6.5 Arrayit Recent Development
11.7 Sengenics
11.7.1 Sengenics Company Detail
11.7.2 Sengenics Business Overview
11.7.3 Sengenics Complementary DNA Microarrays (cDNA) Introduction
11.7.4 Sengenics Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.7.5 Sengenics Recent Development
11.8 Biometrix Technology
11.8.1 Biometrix Technology Company Detail
11.8.2 Biometrix Technology Business Overview
11.8.3 Biometrix Technology Complementary DNA Microarrays (cDNA) Introduction
11.8.4 Biometrix Technology Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.8.5 Biometrix Technology Recent Development
11.9 Savyon Diagnostics
11.9.1 Savyon Diagnostics Company Detail
11.9.2 Savyon Diagnostics Business Overview
11.9.3 Savyon Diagnostics Complementary DNA Microarrays (cDNA) Introduction
11.9.4 Savyon Diagnostics Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.9.5 Savyon Diagnostics Recent Development
11.10 WaferGen
11.10.1 WaferGen Company Detail
11.10.2 WaferGen Business Overview
11.10.3 WaferGen Complementary DNA Microarrays (cDNA) Introduction
11.10.4 WaferGen Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.10.5 WaferGen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.